0.10Open0.10Pre Close0 Volume40 Open Interest10.00Strike Price0.00Turnover124.36%IV29.49%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.1350Delta0.1358Gamma78.00Leverage Ratio-0.0174Theta0.0003Rho10.53Eff Leverage0.0028Vega
INmune Bio Stock Discussion
• $SpringWorks Therapeutics(SWTX.US)$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences(ROIV.US)$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen(OCGN.US)$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Skyline(SKY.US)$ +4.4% (In reaction to earnings)
• $NetEase(NTES.US)$ +4.1% (In...
No comment yet